GlassScriptPhysician profile
Christopher Alan Defalco
NPI 1306101092
$11,013.49
in general payments reported to CMS, 2019-2025
12 companies · $97.03 in 2025
The $97.03 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,036 · 2020: $3,653 · 2021: $1,292 · 2022: $576 · 2023: $263 · 2024: $97.04 · 2025: $97.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $457.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $456.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Crossroads Orthopedics, LLC | $8,199.54 | 2019-2021 | |
| Arthrex, INC. | $1,265.48 | 2020-2022 | |
| Stryker Corporation | $319.39 | 2019-2023 | Triathlon, Trident, Mako |
| Zimmer Biomet Holdings, INC. | $300.46 | 2019-2022 | |
| Acumed LLC | $225.43 | 2019-2020 | |
| Medacta USA, INC. | $221.00 | 2022-2025 | Primary Shoulder, Reverse Shoulder, Gmk Sphere |
| Depuy Synthes Sales INC. | $198.66 | 2019-2023 | Truespan Orthocord, Dynatape, Vapr |
| Smith+Nephew, INC. | $184.89 | 2020-2025 | Journey, Journey II |
| Djo, LLC | $35.88 | 2023-2024 | Donjoy, Cmf |
| Mf Med | $26.00 | 2025 | |
| Pacira Therapeutics, INC. | $20.99 | 2020 | |
| Linvatec Corporation | $15.77 | 2023 | Allograft Tissue, Biobrace 23mm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Defalco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.